Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.75
+0.32 (0.83%)
At close: Jul 2, 2024, 3:59 PM
38.50
-0.25 (-0.65%)
After-hours: Jul 2, 2024, 4:00 PM EDT
CALT Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CALT stock have an average target of 37.5, with a low estimate of 18 and a high estimate of 50. The average target predicts a decrease of -3.23% from the current stock price of 38.75.
Analyst Consensus: Hold
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for CALT stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | +0.65% | May 31, 2024 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $58 → $39 | Strong Buy → Hold | Downgrades | $58 → $39 | +0.65% | May 28, 2024 |
Stifel | Stifel | Strong Buy → Hold Downgrades $55 → $40 | Strong Buy → Hold | Downgrades | $55 → $40 | +3.23% | May 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | +0.65% | May 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +16.13% | May 24, 2024 |
Financial Forecast
Revenue This Year
2.12B
from 1.21B
Increased by 75.49%
Revenue Next Year
3.44B
from 2.12B
Increased by 62.56%
EPS This Year
2.94
from -17.38
EPS Next Year
17.16
from 2.94
Increased by 484.50%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.8B | 4.7B | 6.9B | 8.2B | 9.1B |
Avg | 2.1B | 3.4B | 4.9B | 6.1B | 6.4B |
Low | 1.8B | 2.6B | 3.1B | 3.8B | 3.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 131.3% | 122.6% | 99.2% | 69.1% | 48.4% |
Avg | 75.5% | 62.6% | 41.4% | 25.9% | 3.7% |
Low | 46.9% | 22.9% | -10.2% | -22.1% | -36.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.56 | 34.34 | 66.15 | 104.52 | 142.94 |
Avg | 2.94 | 17.16 | 33.76 | 102.52 | 140.21 |
Low | -1.34 | 9.45 | 16.30 | 97.55 | 133.41 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 1,069.6% | 285.5% | 209.6% | 39.4% |
Avg | - | 484.5% | 96.7% | 203.7% | 36.8% |
Low | - | 221.8% | -5.0% | 189.0% | 30.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.